Printer Friendly

West, Swissfillon Partner on Fill-Finish SmartDose Delivery Platform.

West has partnered with Swissfillon AG, a provider of aseptic fill and finish services to pharma and biopharma companies, for a non-exclusive global collaboration to provide fill-finish capabilities to customers using West's SmartDose drug delivery platform for complex molecules.

Through the collaboration, West aims to be able to deliver an integrated solution with filled Daikyo Crystal Zenith cartidges for the SmartDose wearable injector, which is expected to accelerate clinical development. This new collaboration is expected to offer customers a clinical fill-finish capability later this year.

"We are very pleased to partner with Swissfillon and expand our ability to offer a fully innovative drug delivery solution supporting our customers' journey from molecule to market. It combines Swissfillon's fill-finish expertise with West's proprietary drug delivery technology to deliver a streamlined solution that meets the unique needs of pharmaceutical manufacturers around the world," said Karen Flynn, senior vice president and chief commercial officer, West.

"We are excited to work with West to bring our fill-finish capabilities to West's SmartDose platform offering," said Daniel Kehl, chief executive officer, Swissfillon AG. "We look forward to partnering together to support pharmaceutical and biotech customers to deliver innovative combination drug products to patients."

West's SmartDose drug delivery platform enables patients to self-administer medication in accordance with their prescribed treatment. West developed the SmartDose platform with human factors testing and analysis to understand the interaction between the patient and the delivery system. An integrated solution for the containment and delivery of injectable medications, the SmartDose platform features a silicone-free Daikyo Crystal Zenith cartridge and a Flurotec barrier film coated piston primary containment system.

Clinical fill-finish services are part of West's new Integrated Solutions Program that offers customers services from molecule to market with containment and delivery solutions for combination products; analytical testing services; regulatory support; and device manufacturing, assembly and drug handling designed for any stage of the drug development lifecycle.

More info:

COPYRIGHT 2019 Rodman Publishing
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2019 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:READER SHOWCASE
Publication:Contract Pharma
Date:Mar 1, 2019
Previous Article:Shimadzu Releases New Gradient System Protein Sequencers.
Next Article:FloDesign Sonics Launches First ekko Line Product.

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters